Elanco Animal Health Incorporated ( ELAN) - Key Metrics
ELAN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.74 | $0.11 | $0.55 | $0.49 |
| 2026Q1 | $2.75 | $0.11 | $0.03 | -$0.08 |
| 2025Q4 | $2.30 | -$0.56 | $0.22 | $0.09 |
| 2025Q3 | $2.29 | -$0.07 | $0.44 | $0.26 |
| 2025Q2 | $2.50 | $0.02 | $0.48 | $0.36 |
ELAN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 55.93 |
| 2026Q1 | 0% | 54.39 |
| 2025Q4 | 0% | -10.10 |
| 2025Q3 | 0% | -71.93 |
| 2025Q2 | 0% | 160.81 |
ELAN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.98% | 0% |
| 2026Q1 | -0.32% | 0% |
| 2025Q4 | 0.41% | 0% |
| 2025Q3 | 1.27% | 0% |
| 2025Q2 | 2.54% | 0% |
ELAN
Price: $22.41
52 week price:
Earnings Per Share: -0.41 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 5.1 million
Market Capitalization: 11.1 billion